...
机译:CD40-MAB和CD40L-AB共刺激滞后性植物寿命致畸心外膜膜与全球优先成功的长期生存
Univ Munich LMU Dept Cardiac Surg Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Dept Cardiac Surg Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Walter Brendel Ctr Munich Germany;
Univ Munich LMU Dept Anaesthesiol Munich Germany;
Univ Munich LMU Dept Mol Anim Breeding &
Biotechnol Munich Germany;
Univ Munich LMU Dept Mol Anim Breeding &
Biotechnol Munich Germany;
Univ Massachusetts Med Sch MassBiol Boston MA 02125 USA;
Univ Munich LMU Dept Vet Pathol Munich Germany;
Revivicor Inc Blacksburg VA USA;
Univ Munich LMU Dept Cardiac Surg Munich Germany;
Lund Univ Dept Cardiothorac Surg Lund Sweden;
Univ Munich LMU Dept Cardiac Surg Munich Germany;
机译:CD40-MAB和CD40L-AB共刺激滞后性植物寿命致畸心外膜膜与全球优先成功的长期生存
机译:在原位心脏异种术中的突破(Oxhtx):完成使用CD40MAB共抑制阻止的8例中的第一个成功的长期存活(第90天和多终止于第90天和多195天)的临床前寿命支持的猪对狒狒牛仔研究 用于免疫抑制
机译:使用CD40MAB或CD40L-AB共刺激阻断,Galko / HCD46 / HTM-转基因猪心脏进入狒狒(40天生存期)的原位心脏癌
机译:猪到狒狒异种心脏移植-猪血栓素转基因猪的初步实验和三种基于刺激封锁的治疗方案的比较
机译:猪至狒狒异位心脏移植 - 人类血统调节素的猪转基因探究性初步体验,并比较了三种成本抑制的封锁方案